| Literature DB >> 27819857 |
Dharmender Malik1, Rajender K Basher, Bhagwant Rai Mittal, Tarun Kumar Jain, Amanjit Bal, Shrawan Kumar Singh.
Abstract
Ga-labeled prostate-specific membrane antigen ligand PET-CT has emerged as a promising technique to evaluate the extent of disease in patients with prostate carcinoma. We are reporting a 63-year-old man with prostatic carcinoma subjected to Ga-prostate-specific membrane antigen ligand PET-CT for initial staging. In addition to the radiotracer uptake in known primary site (prostate), focal increased radiotracer uptake was also noticed in the left breast. Subsequent biopsy of the breast lesion revealed PASH (pseudoangiomatous stromal hyperplasia), which is a benign mesenchymal proliferative lesion that may present clinically as palpable mass requiring further evaluation to rule out malignancy.Entities:
Mesh:
Substances:
Year: 2017 PMID: 27819857 DOI: 10.1097/RLU.0000000000001445
Source DB: PubMed Journal: Clin Nucl Med ISSN: 0363-9762 Impact factor: 7.794